Tazarotene
Products in Health Canada’s databases that list Tazarotene as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 6
- 2 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 10
- Products in all
- 6
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| ARAZLO (0.045 %) | 02517868 | Marketed | Bausch Health, Canada Inc. | |
| DUOBRII (0.045 %) | 02499967 | Marketed | Bausch Health, Canada Inc. | |
| TAZORAC (0.05 %) | 02230784 | Cancelled Post Market | Allergan Inc | |
| TAZORAC (0.1 %) | 02230785 | Cancelled Post Market | Allergan Inc | |
| TAZORAC (0.05 %) | 02243894 | Cancelled Post Market | Allergan Inc | |
| TAZORAC (0.1 %) | 02243895 | Cancelled Post Market | Allergan Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- ARAZLONovember 28, 2025 · NOC 36449
- DUOBRIIJune 10, 2025 · NOC 35504
- DUOBRIIJuly 13, 2023 · NOC 31209
- DUOBRIIJune 22, 2022 · NOC 28440
- ARAZLOJuly 8, 2021 · NOC 26223
- DUOBRIIJune 10, 2020 · NOC 23758
- TAZORACJune 5, 2002 · NOC 841
- TAZORACMay 15, 2002 · NOC 843
- TAZORACMay 30, 2001 · NOC 2640
- TAZORACFebruary 25, 1997 · NOC 4122